CM-AT not checked

Curemark

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 3 trial completes
Trials
1 active
2 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
How it’s given
“Single unit does powder of active substance (CM-AT) administered 3 times per day”In the company’s words, NCT02649959 on ClinicalTrials.gov
Tested for
Autism
Main trialPhase 3
“This is a Phase III, open label extension study evaluating the continued safety and efficacy of CM-AT in pediatric patients with autism with all levels of fecal chymotrypsin.”In the company’s words, NCT02649959 on ClinicalTrials.gov

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials2

TrialPhaseCompletesWhat it tests
Phase 3Active, not recruiting Jan 2028 An Open Label Study of CM-AT for the Treatment of Children With Autism
Phase 3Completed 22 Dec 2017 A Trial of CM-AT in Children With Autism With All Levels of FCT (The Blum Study)
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow CM-AT

Following is part of Solo: you see every change to CM-AT the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in